Have questions? Visit https://www.reddit.com/r/SNPedia

rs2230641

From SNPedia

Orientationminus
Stabilizedminus
Make rs2230641(C;C)
Make rs2230641(C;T)
Make rs2230641(T;T)
ReferenceGRCh38 38.1/141
Chromosome5
Position87399457
GeneCCNH
is asnp
is mentioned by
dbSNPrs2230641
ebirs2230641
HLIrs2230641
Exacrs2230641
Varsomers2230641
Maprs2230641
PheGenIrs2230641
hapmaprs2230641
1000 genomesrs2230641
hgdprs2230641
ensemblrs2230641
gopubmedrs2230641
geneviewrs2230641
scholarrs2230641
googlers2230641
pharmgkbrs2230641
gwascentralrs2230641
openSNPrs2230641
23andMers2230641
23andMe allrs2230641
SNP Nexus

SNPshotrs2230641
SNPdbers2230641
MSV3drs2230641
GWAS Ctlgrs2230641
Merged fromRs2266690
GMAF0.1382
Max Magnitude
? (C;C) (C;T) (T;T) 28
[PMID 16465622OA-icon.png] Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.


[PMID 18708406OA-icon.png] Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China.


[PMID 18711149OA-icon.png] Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.


[PMID 18854777OA-icon.png] Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.


[PMID 19074885] Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.


[PMID 19270000OA-icon.png] Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.


[PMID 20141440OA-icon.png] Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.

GET Evidence
CCNH-V270A
aa_change Val270Ala
aa_change_short V270A
impact not reviewed
qualified_impact Insufficiently evaluated not reviewed
overall_frequency 0.173173
summary



[PMID 24351404] Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study